Chang-yong Yang

SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models

Lei Wang, H. Quan, S. Gou, 2019, Acta Pharmacologica Sinica.